live resin
Member
I just read a sci journal article discussing possible negative interactions between CBD, CBN, and THC and pharmaceuticals that use the multidrug transporter ABCG2. Cannabinoids are novel ABCG2 inhibititors, thus, drugs that are ABCG2 substrates may not be suitable for co-administration with cannabinoids.
Here's the link
http://www.ncbi.nlm.nih.gov/m/pubmed/17906686/
Here's the link
http://www.ncbi.nlm.nih.gov/m/pubmed/17906686/